Additional File 4 of the EGFR-HSF1 Axis Accelerates the Tumorigenesis of Pancreatic Cancer

Weikun Qian,Ke Chen,Tao Qin,Ying Xiao,Jie Liu,Yangyang Yue,Cancan Zhou,Jiguang Ma,Wanxing Duan,Jing Liu,Liang Han,Lili Li,Xipeng Shen,Zheng Wu,Qingyong Ma,Zheng Wang

DOI: https://doi.org/10.6084/m9.figshare.13551078

2021-01-01

Abstract:Additional file 4: Table S3. Source files of bioinformatics analysis on EGFR pathway (GEO GSE98399 datasets).

What problem does this paper attempt to address?

The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer

Weikun Qian,Ke Chen,Tao Qin,Ying Xiao,Jie Li,Yangyang Yue,Cancan Zhou,Jiguang Ma,Wanxing Duan,Jianjun Lei,Liang Han,Li Li,Xin Shen,Zheng Wu,Qingyong Ma,Zheng Wang

DOI: https://doi.org/10.1186/s13046-020-01823-4

2021-01-09

Abstract:Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant diseases because of its non-symptomatic tumorigenesis. We previous found heat shock factor 1 (HSF1) was critical for PDAC progression and the aim of this study was to clarified the mechanisms on early activation of HSF1 and its role in the pancreatic cancer tumorigenesis. Methods The expression and location of HSF1 on human or mice pancreatic tissues were examined by immunohistochemically staining. We mainly used pancreatic acinar cell 3-dimensional (3D) culture and a spontaneous pancreatic precancerous lesion mouse model called LSL-Kras G12D/+ ; Pdx1-Cre (KC) (and pancreatitis models derived from KC mice) to explore the pro-tumorigenesis mechanisms of the HSF1 in vitro and in vivo. Bioinformatics and molecular experiments were used to explore the underlying mechanisms between HSF1 and epidermal growth factor receptor (EGFR). Results In this study, we found that pharmacological inhibition of HSF1 slowed pancreatic cancer initiation and suppressed the pancreatitis-induced formation of pancreatic precancerous lesion. Next, bioinformatics analysis revealed the closely linked between HSF1 and EGFR pathway and we also confirmed their parallel activation in pancreatic precancerous lesions. Besides, the pharmacological inhibition of EGFR suppressed the initiation of pancreatic cancer and the activation of HSF1 in vivo. Indeed, we demonstrated that the EGFR activation that mediated pancreatic cancer tumorigenesis was partly HSF1-dependent in vitro. Conclusion Hence, we concluded that the EGFR-HSF1 axis promoted the initiation of pancreatic cancer.

oncology
Additional File 4 of Cancer-associated Fibroblast Infiltration in Gastric Cancer: the Discrepancy in Subtypes Pathways and Immunosuppression

Ling Xu,Yao Li,Jingkun Qu,Longnian Lin,Ning Lü,Jiansheng Wang,Jia Zhang

DOI: https://doi.org/10.6084/m9.figshare.15087379

2021-01-01

Abstract:Additional file 4: TGF-beta pathway, Hedgehog pathway and RTKs ligands list.
Additional File 1 of Genetic Alterations and Functional Networks of M6a RNA Methylation Regulators in Pancreatic Cancer Based on Data Mining

Juan Zeng,Heying Zhang,Yi Tan,Zhe Wang,Yunwei Li,Xiaoguang Yang

DOI: https://doi.org/10.6084/m9.figshare.15086087

2021-01-01

Abstract:Additional file 1. Antibodies for WB and primers for RT-qPCR used in this study.
Additional File 4 of Multi-omics Analysis of Tumor Angiogenesis Characteristics and Potential Epigenetic Regulation Mechanisms in Renal Clear Cell Carcinoma

Wenzhong Zheng,Shiqiang Zhang,Huimin Guo,Xiaobao Chen,Zhangcheng Huang,Shaoqin Jiang,Mengqiang Li

DOI: https://doi.org/10.6084/m9.figshare.14299615

2021-01-01

Abstract:Additional file 4: Table S1. Ten independent angiogenesis reference gene sets.
Additional File 5 of A Pan-Kidney Cancer Study Identifies Subtype Specific Perturbations on Pathways with Potential Drivers in Renal Cell Carcinoma

Xiaohui Zhan,Yusong Liu,Christina Y. Yu,Tianfu Wang,Jie Zhang,Dong Ni,Kun Huang

DOI: https://doi.org/10.6084/m9.figshare.13498094

2020-01-01

Abstract:Additional file 5: Table S5. Potential upstream regulators.
Additional File 4 of the LINC00623/NAT10 Signaling Axis Promotes Pancreatic Cancer Progression by Remodeling Ac4c Modification of Mrna

Zengyu Feng,Kai Qin,Juyong Liang,Minmin Shi,Shiwei Zhao,Huaiyu Liang,Baiyong Shen,Chenghong Peng,Hao Chen,Lingxi Jiang

DOI: https://doi.org/10.6084/m9.figshare.20508488

2022-01-01

Abstract:Additional file 4: Table S4. Antibodies used in this study.
Additional File 29 of Proteogenomic Insights into the Biology and Treatment of Pancreatic Ductal Adenocarcinoma

Yexin Tong,Mingjun Sun,Lingli Chen,Yunzhi Wang,Jinwen Feng,Lingling Li,Xuan Zhang,Yumeng Cai,Jingbo Qie,Yanrui Pang,Ziyan Xu,Jingxia Zhao,Xiaolei Zhang,Yang Liu,Sha Tian,Zhaoyu Qin,Fan Zhang,Jiajun Zhu,Yifan Xu,Wenhui Lou,Yuan Ji,Jian Zhao,Fuchu He,Yingyong Hou,Ding Chen

DOI: https://doi.org/10.6084/m9.figshare.21628900

2022-01-01

Abstract:Additional file 29: Table S7. Characterization of Immune Infiltration in PDAC. Table S7A Matrix of xCell signatures significantly altered in 5 immune subgroups. Table S7B Matrix describing the expression of proteins in 5 immune subgroups. Table S7C Matrix of GSVA scores of pathways significantly altered in 5 immune subgroups, transcriptome level. Table S7D Matrix of amplification/deletion events of genes in 5 immune subgroups. Table S7E Matrix describing the expression of proteins involved in TCA cycle.
Additional File 1 of Metabolic Classifications of Renal Cell Carcinoma Reveal Intrinsic Connections with Clinical and Immune Characteristics

Le Li,Zheng Chao,Un Waikeong,Jun Xiao,Yili Ge,Yanan Wang,Zezhong Xiong,Sheng Ma,Zhihua Wang,Zhiquan Hu,Xing Zeng

DOI: https://doi.org/10.6084/m9.figshare.22610398

2023-01-01

Abstract:Additional file 1. Gsea results of 3 clusters.
Fig S1-S8 from Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer

Junchen Liu,Guo Chen,Zezhen Liu,Shaoyou Liu,Zhiduan Cai,Pan You,Yuepeng Ke,Li Lai,Yun Huang,Hongchang Gao,Liangcai Zhao,Helene Pelicano,Peng Huang,Wallace L. McKeehan,Chin-Lee Wu,Cong Wang,Weide Zhong,Fen Wang

DOI: https://doi.org/10.1158/0008-5472.22419839.v1

2023-01-01

Abstract:This file containing all the supplemental data supporting the statements indicated in the manuscripts.
Additional File 14 of M6a Eraser FTO Impairs Gemcitabine Resistance in Pancreatic Cancer Through Influencing NEDD4 Mrna Stability by Regulating the PTEN/PI3K/AKT Pathway

Kai Lin,Endi Zhou,Tongguo Shi,Siqing Zhang,Jinfan Zhang,Ziruo Zheng,Yuetian Pan,Wentao Gao,Yabin Yu

DOI: https://doi.org/10.6084/m9.figshare.24002811

2023-01-01

Abstract:Additional file 14: Supplementary file 3. RNA-seq after FTO overexpression in CFPAC-GM cells.
Additional File 3 of Construction of a Prognostic Model with Histone Modification-Related Genes and Identification of Potential Drugs in Pancreatic Cancer

Yuan Chen,Ruirong Xu,Rexiati Ruze,Jinshou Yang,Huanyu Wang,Jianlu Song,Lei You,Yuming Wang,Yupei Zhao

DOI: https://doi.org/10.6084/m9.figshare.14738772

2021-01-01

Abstract:Additional file 3: Table S3. Genes related to histone modification obtained from the GSEA website.
Additional File 3 of Circulating Tumor DNA As a Prognostic Marker in High-Risk Endometrial Cancer

Weiwei Feng,Jun Nan,Haining Jiao,Jun Chen,Chen‐Hua Yan,Yueru Zhang,Menghan Zhu,Chongying Zhu,Lifei Shen,Wuqiang Long

DOI: https://doi.org/10.6084/m9.figshare.13710998

2021-01-01

Abstract:Additional file 3: Table S3. Pathogenic/Likely pathogenic mutations* in detected cases.
Supplementary Figures 5 - 6 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Ling Li,Wenhua Tang,Xiaoqing Wu,David Karnak,Xiaojie Meng,Rachel Thompson,Xinbao Hao,Yongmin Li,Xiaotan T. Qiao,Jiayuh Lin,James Fuchs,Diane M. Simeone,Zhi-Nan Chen,Theodore S. Lawrence,Liang Xu

DOI: https://doi.org/10.1158/1078-0432.22446371.v1

2023-01-01

Abstract:PDF file - 451K, Figure S5: CyPA promotes HAb18G/CD147-CD44s-pSTAT3 signaling and correlated pancreatic cell growth (related to Figure 2, 3). Figure S6: HAb18G/CD147 and CD44s are co-expressed and associated in pancreatic cancer (related to Figure 4).
Additional File 19 of Single-cell RNA-seq Reveals the Genesis and Heterogeneity of Tumor Microenvironment in Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant-Cells

Xinbo Wang,Jiaying Miao,Sizhen Wang,Rongxi Shen,Shuo Zhang,Yurao Tian,Min Li,Daxing Zhu,Anlong Yao,Wei Bao,Qun Zhang,Xingming Tang,Xinyun Wang,Jieshou Li

DOI: https://doi.org/10.6084/m9.figshare.20130935

2022-01-01

Abstract:Additional file 19: Table S11. beam_markers.
Additional File 11: of A Positive Feed-Forward Loop Between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 Signaling Promotes Proliferation and Metastasis of Clear Cell Renal Cell Carcinoma

Wei Zhai,Ronggang Zhu,Junjie Ma,Dongkui Gong,Haimin Zhang,Jin Zhang,Yonghui Chen,Yong Huang,Junhua Zheng,Handong Wang

DOI: https://doi.org/10.6084/m9.figshare.7961345

2019-01-01

Abstract:Table S8. JMY expression and paitientsâ survival time from TCGA KIRC dataset. (XLS 19 kb)
Additional File 4 of LncRNA-PACERR Induces Pro-Tumour Macrophages Via Interacting with Mir-671-3p and M6a-Reader IGF2BP2 in Pancreatic Ductal Adenocarcinoma

Yihao Liu,Minmin Shi,Xingfeng He,Yibo Cao,Pengyi Liu,Fanlu Li,Xiaxing Deng,Chenlei Wen,Qimin Zhan,Zhiwei Xu,Jiancheng Wang,Baofa Sun,Baiyong Shen

DOI: https://doi.org/10.6084/m9.figshare.19728742

2022-01-01

Abstract:Additional file 4. All primer sequences used in the qPCR process.
Additional File 21 of Pan-cancer Analysis of Cuproptosis Regulation Patterns and Identification of Mtor-Target Responder in Clear Cell Renal Cell Carcinoma

Shichao Long,Ya Wang,Yuqiao Chen,Tianshu Fang,Yuanbing Yao,Kai Fu

DOI: https://doi.org/10.6084/m9.figshare.21303485

2022-01-01

Abstract:Additional file 21: Table S8. Clinical baseline data of CEScore in pan-cancer.
Supplementary Figure 4 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Ling Li,Wenhua Tang,Xiaoqing Wu,David Karnak,Xiaojie Meng,Rachel Thompson,Xinbao Hao,Yongmin Li,Xiaotan T. Qiao,Jiayuh Lin,James Fuchs,Diane M. Simeone,Zhi-Nan Chen,Theodore S. Lawrence,Liang Xu

DOI: https://doi.org/10.1158/1078-0432.22446374

2023-01-01

Abstract:PDF file - 263K, The effects of HAb18G/CD147 promoting pancreatic tumor development are confirmed with pGIPZ and pTRIPZ CD147 shRNA (related to Figure 1).
MOESM4 of EGFR Mutation: Novel Prognostic Factor Associated with Immune Infiltration in Lower-Grade Glioma; an Exploratory Study

Zhaonian Hao,Dongsheng Guo

DOI: https://doi.org/10.6084/m9.figshare.11321033

2019-01-01

Abstract:Additional file 4: Table S4. PPI hub genes. The identified hub genes and the outputs of Log-rank tests. (CSV 166 kb)
Additional File 5 of Identification of DNA Repair-Related Genes Predicting Pathogenesis and Prognosis for Liver Cancer

Wenjing Zhu,Qiliang Zhang,Min Liu,Meixing Yan,Xiao Chu,Yongchun Li

DOI: https://doi.org/10.6084/m9.figshare.13669395

2021-01-01

Abstract:Additional file 5. The raw data of GSE101728 from GEO database.

Additional File 4 of the EGFR-HSF1 Axis Accelerates the Tumorigenesis of Pancreatic Cancer

The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer

Additional File 4 of Cancer-associated Fibroblast Infiltration in Gastric Cancer: the Discrepancy in Subtypes Pathways and Immunosuppression

Additional File 1 of Genetic Alterations and Functional Networks of M6a RNA Methylation Regulators in Pancreatic Cancer Based on Data Mining

Additional File 4 of Multi-omics Analysis of Tumor Angiogenesis Characteristics and Potential Epigenetic Regulation Mechanisms in Renal Clear Cell Carcinoma

Additional File 5 of A Pan-Kidney Cancer Study Identifies Subtype Specific Perturbations on Pathways with Potential Drivers in Renal Cell Carcinoma

Additional File 4 of the LINC00623/NAT10 Signaling Axis Promotes Pancreatic Cancer Progression by Remodeling Ac4c Modification of Mrna

Additional File 29 of Proteogenomic Insights into the Biology and Treatment of Pancreatic Ductal Adenocarcinoma

Additional File 1 of Metabolic Classifications of Renal Cell Carcinoma Reveal Intrinsic Connections with Clinical and Immune Characteristics

Fig S1-S8 from Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer

Additional File 14 of M6a Eraser FTO Impairs Gemcitabine Resistance in Pancreatic Cancer Through Influencing NEDD4 Mrna Stability by Regulating the PTEN/PI3K/AKT Pathway

Additional File 3 of Construction of a Prognostic Model with Histone Modification-Related Genes and Identification of Potential Drugs in Pancreatic Cancer

Additional File 3 of Circulating Tumor DNA As a Prognostic Marker in High-Risk Endometrial Cancer

Supplementary Figures 5 - 6 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

Additional File 19 of Single-cell RNA-seq Reveals the Genesis and Heterogeneity of Tumor Microenvironment in Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant-Cells

Additional File 11: of A Positive Feed-Forward Loop Between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 Signaling Promotes Proliferation and Metastasis of Clear Cell Renal Cell Carcinoma

Additional File 4 of LncRNA-PACERR Induces Pro-Tumour Macrophages Via Interacting with Mir-671-3p and M6a-Reader IGF2BP2 in Pancreatic Ductal Adenocarcinoma

Additional File 21 of Pan-cancer Analysis of Cuproptosis Regulation Patterns and Identification of Mtor-Target Responder in Clear Cell Renal Cell Carcinoma

Supplementary Figure 4 from HAb18G/CD147 Promotes Pstat3-Mediated Pancreatic Cancer Development Via CD44s

MOESM4 of EGFR Mutation: Novel Prognostic Factor Associated with Immune Infiltration in Lower-Grade Glioma; an Exploratory Study

Additional File 5 of Identification of DNA Repair-Related Genes Predicting Pathogenesis and Prognosis for Liver Cancer